ACOG Alpha Cognition: Year-over-year net earnings per share growth for the last 12 months
The precision of biomaterial transport is critical for Alzheimer's therapy, as confirmed by the quarterly EPS evolution, where the parameter settled at 38.30. This trend is supported by adherence to laboratory eco-standards in the absence of large-scale plants. The ultimate success of Alpha Cognition (ACOG) is based on the scientific expertise of its management and upcoming FDA verdicts regarding their innovative drugs.
Metric breakdowns and analytics for Alpha Cognition (ACOG)
- share price and expert price forecast:
- company stock capitalization data:
- book capitalization indicators:
- business debt structure and liquidity details:
Total Debt to Capital Alpha Cognition|ACOG - Long-Term Indebtedness to Equity|Short-Term Debt to Equity alphacognition.com|ACOG - Company Aggregate Debt|Debts to Book Capitalization Alpha Cognition Corp|ACOG - Long-Term Debt Volume|Company Current Liabilities Alpha Cognition|Quick Ratio alphacognition.com
- earnings and valuation multiples indicators:
ACOG - Net Financial Result|Expected Profit Alpha Cognition|ACOG - Market Cap to Earnings|Future Price to Earnings alphacognition.com|ACOG - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Alpha Cognition Corp|ACOG - Operating profit EBITDA|Net earnings per share (EPS TTM) Alpha Cognition|ACOG - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months alphacognition.com|ACOG - Earnings per share growth rate in current year|Earnings growth forecast for next year Alpha Cognition
Summary company analysis:Alpha Cognition Inc - ACOG
The selection of high-quality issuers is based on a rigorous analysis of profit dynamics and capital efficiency. This indicator captures the percentage change in net income per share between the current and previous quarters. For Alpha Cognition (ACOG), this calculation reflects financial stability during the development of the ALPHA-1062 drug. Optimizing the formula for the Alzheimer's medication directly impacts future monetization. By analyzing the quarter-over-quarter EPS dynamics, an investor identifies the asset's real market value.
Competitors of Alpha Cognition (ACOG)
BIIB: Quarterly EPS earnings growth|Neurocrine (NBIX) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGC|AXSM: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACAD|Year-over-year net earnings per share growth for the last 12 months xenon-pharma.com XENE|Year-over-year earnings per share growth for the last twelve months Viking Therapeutics, Inc. VKTX|Supernus Pharmaceuticals, Inc. (SUPN) - Earnings per share growth in annualized terms for the last twelve months|Catalyst Pharmaceuticals Inc - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year Denali Corp (DNLI)|Harmony Biosciences (HRMY) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months BHVN|AMLX (Amylyx Pharmaceuticals, Inc.) - Quarterly EPS earnings growth|Trevi Therapeutics Inc (TRVI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months PRAX (Praxis Medicines)|Year-over-year earnings per share growth rate for the last twelve months AVXL|Quarterly EPS earnings growth CBLL (CeriBell, Inc.)|Year-over-year net earnings per share change for the last twelve months prothena.com (PRTA)|ALEC - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Annexon Biosciences|omeros.com (OMER) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months NGNE|ACIU (AC Immune) - Quarterly EPS earnings growth|Quarterly EPS earnings growth voyagertherapeutics.com|Quarterly EPS earnings growth NMRA|Year-over-year net earnings per share growth for the last 12 months Scilex Holding SCLX|Year-over-year earnings per share growth for the last twelve months Tevogen Bio Holdings, Inc. TVGN|cogrx.com (CGTX) - Earnings per share growth in annualized terms for the last twelve months|Inhibikase Therapeutics - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year cassavasciences.com (SAVA)|assertiotx.com (ASRT) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months COYA|VTGN (VistaGen Therapeutics, Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ovid Rx OVID|Year-over-year net earnings per share growth for the last 12 months ABOS (Acumen Pharmaceuticals)|Quarterly EPS earnings growth cervomed.com (CRVO)|Year-over-year earnings per share growth for the last twelve months Alterity Therapeutics Limited ATHE|Year-over-year earnings per one share growth for the last 12 months CLNN|PEPG - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months jupiterneurosciences.com|RLMD: Quarterly EPS earnings growth|annovisbio.com (ANVS) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Grace Therapeutics Inc|Year-over-year earnings per share growth for the last twelve months AIFF|Year-over-year earnings per share growth for the last twelve months Klotho Neurosciences Inc (KLTO)|NRSN: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth RVPH (Reviva Pharmaceuticals)|Year-over-year earnings per one share growth for the last 12 months MTVA|NeurAxis - Quarterly EPS earnings growth|HSDT - Quarterly EPS earnings growth|PASG (passagebio.com) - Year-over-year net earnings per share growth for the last 12 months|Neuphoria Therapeutics - Year-over-year earnings per one share growth for the last 12 months|NERV (Minerva Neurosciences) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months athira.com (ATHA)|Year-over-year earnings per share growth for the last twelve months Addex Therapeutics Ltd (ADXN)|ALZN - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth CYCN (Cyclerion Therapeutics, Inc.)|Net earnings per share growth for the trailing year Protagenic Therapeutics Inc.|KTTA - Year-over-year earnings per share growth for the last twelve months|CRGT (Cortigent, Inc.) - Year-over-year earnings per share growth for the last 12 months|ATXI: Quarterly EPS earnings growth|BCLI - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CARA|CHRO (Chromocell) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth ELYM|Year-over-year net earnings per share change for the last twelve months intracellulartherapies.com|Year-over-year earnings per share growth for the last twelve months Longboard Pharmaceuticals, Inc. LBPH|Marinus Pharmaceuticals Inc (MRNS) - Earnings per share growth in annualized terms for the last twelve months|NKGN - Year-over-year earnings per share growth for the last twelve months|NRBO (NeuroBo Pharma) - Year-over-year earnings per share growth for the last 12 months|SAGE: Quarterly EPS earnings growth|synaptogen.com (SNPX) - Quarterly EPS earnings growth|TRVN (Trevena) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Vigil Neuro (VIGL)|Year-over-year earnings per share growth for the last twelve months Anew Medical, Inc. (WENA)|CERE - Earnings per share growth in annualized terms for the last twelve months
